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G E N E R A L  P H A R M A C O L O G Y  
 
Pharmacology  is the science about interaction between drugs 
and human organism. Pharmacology is divided into general and 
special pharmacology. General pharmacology studies the general 
laws of drug interaction with human organism. Special 
pharmacology studies the pharmacological groups of drugs and 
individual drugs. Both general and special pharmacology are divided 
into pharmacokinetics  and pharmacodynamics. 
Pharmacokinetics is the section of pharmacology which studies 
the influence of human body upon drugs (absorption, distribution, 
deposition, biotransformation, and excretion from the body).      
Pharmacodynamics is the section of pharmacology which studies 
the action of drugs upon the human organism (biological effects, 
localization, and mechanism of action).  
 
Drug Pharmacokinetics  
 
Penetration of Drugs through Biological Membranes 
 
Prior the influence upon the target organs, drugs penetrate 
through some tissue barriers. There are 5 main mechanisms of 
substance transport through biological membranes (tissue barriers).  
1. Simple diffusion through cellular membranes. It is most 
important mechanism of drug penetration which depends on the 
concentration gradient of substance. Lipophylic drugs penetrate 
through cellular membranes by means of simple diffusion. Drug 
lipophylicity depends on the amount of molecular charge. The higher 
molecular charge, the worse drug solubility in lipids and vice versa. 
The degree of drug ionization depends on pH of tissues and fluids. If 
a drug is the weak acid, it will be weakly ionized in acidic 
environment and its molecules can easily penetrate through 
biological membranes by diffusion. Such drug is prescribed right 
after meal, when a gastric content has extremely low pH. Vice versa, 
weakly basic drug should be taken orally prior meal or in 1.5–2 hours 
after meal (when gastric acidity is minimal). Besides, weakly acidic 
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drugs should be washed down by acidic solutions and weakly basic 
drugs – by basic solutions (e.g., milk or mineral water). 
Plasma pH is 7.4, but different fluids of human organism may 
have other values. Thus, urine pH of adults at morning is 4.8, at 
evening – 7.4. Therefore, weak acids (e.g., aspirin) are reabsorbed 
better from the morning urine that provides its retention in the body.     
2. Filtration through membrane pores is a secondary way of 
drug penetration through biological barriers. Pore diameter is small 
(nearly 4 Å) that makes penetration of larger molecules impossible. 
Only water and small uncharged water-soluble molecules (urea, 
sugars) penetrate through pores by means of filtration. The direction 
of movement depends on concentration difference on both sides of 
the membrane and on the speed of fluid flow through the membrane.  
Drugs with marked polarity are ionized easily and have big 
charge. These drugs do not penetrate through pores and membranes 
(e.g., heparin, myorelaxants). Such drugs are administered by means 
of injection because they are not absorbed in gastrointestinal tract. 
These drugs cannot penetrate through blood-brain and placental 
barriers. 
3. Facilitated diffusion through membrane is possible for some 
substances (glucose, amino acids, etc.). This mode of transport is 
carried out by means of channels with special transporter proteins 
(permeases). Permeases selectively bind with certain substances and 
transport them inside of the cells. Facilitated diffusion is possible 
against concentration gradient.   
4. Active transport is characterized by selectivity to certain 
substances. Unlike facilitated diffusion, active transport needs the 
use of energy which is released due to ATP hydrolysis. Active 
transport is carried out against concentration and electrochemical 
gradients. Thus, some amino acids, nitrogen compounds and their 
derivatives are transported through membranes by means of active 
transport. 
5. Pinocytosis is the uptake of substances by means of vesicle 
formation. The substance contacts with part of membrane with 
following membrane invagination and formation of the vesicle inside 
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which is the substance. This vesicle is separated from the membrane 
and transported inside the cell. For instance, some proteins and 
peptide hormones are transported into the cells by means of 
pinocytosis.  
 
Routes of Drug Administration  
 
There are enteral and parenteral routes of drug administration. 
Enteral routes include routes of drug administration through 
gastrointestinal tract: peroral (oral), sublingual, rectal, and 
administration into duodenum by means of a feeding tube.  
Peroral drug administration is most natural, simple, and 
comfortable route. But this route is not the best one for the urgent 
care. In gastrointestinal tract, drug may be changed under the 
influence of gastric duce and intestinal enzymes. Thus, drug activity 
is reduced or lost completely. A degree and speed of drug absorption 
from gastrointestinal tract depends on presence and quality of food, 
because the food components can slow down the drug absorption due 
to formation of inactive complexes with it. But, sometimes, the 
increase of speed of drug absorption under influence of food 
components is possible.  
Most commonly, drugs are taken in 30–40 minutes prior or in 1–
2 hours after meal. As a rule, the onset of drug action is in 15–40 
minutes after peroral intake. Drugs in coated tablets or in capsules 
are absorbed in small intestine. Lipid-soluble substances are 
absorbed after emulsification by bile acids. After absorption, drug is 
transported through the portal venous system in the liver with the 
following partial biotransformation. After this, drug enters the 
bloodstream and starts acting. As a rule, the drug dose for peroral 
intake is 2–3 times more than for parenteral administration.  It is due 
to drug biotransformation during the first passage through the liver. 
Due to the fact that the drug action is developed only when it is 
entering bloodstream, the term “bioavailability” was proposed. The 
bioavailability is the part of administered drug dose which reaches 
the systemic circulation in unchanged form. Bioavailability is given 
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in the percentage of the administered dose. In intravenous 
administration, medication bioavailability is 100 %.  
When medication is taken sublingually, its absorption develops 
quickly due to intense blood supply of the mucous membrane of the 
mouth. The sublingually taken drug does not undergo the influence 
of gastric juice and gastrointestinal enzymes. Sublingual drug 
absorption is performed through superior vena cava system that 
provides the drug entering the bloodstream, bypassing the liver. 
These factors provide the faster and more marked drug effect than 
during peroral intake.   
Rectal drug administration is used if peroral intake is impossible 
or for the medication influence on mucous membrane of rectum. This 
route provides quite fast onset of drug action. Nearly 50 % of rectally 
administered dose enters inferior vena cava and then the liver. 
Another part of dose enters the bloodstream bypassing the liver. 
Therefore, the drug effect in case of rectal administration is 20–25 % 
higher than in case of peroral intake. A volume of the therapeutic 
enema is about 25–100 mL. If administered rectally, drug irritates the 
mucosa, therefore the starch mucus is added to drug solution (in 
amount 30–50 % of general volume of enema). For the drug 
influence on rectal mucosa (hemorrhoids, rectal cracks, etc.), the 
drugs are administered in form of rectal suppositories that provides 
prolonged local effect.  
Parenteral routes of drug administration are used for both 
resorptive (subcutaneously, intramuscularly, intravenously, etc.) and 
local (administration into body cavies) effects. Parenteral drug 
administration is characterized by some advantages: dosing accuracy, 
fast effect development, less dose in comparison with enteral intake, 
etc. But along with it, injections can cause contamination (must 
adhere to sterility), possibility of overdose, or local complications on 
the injection site (thrombosis, damage of vascular endothelium, etc.).  
Intravenous route provides the fast effect and fast appearance of 
high drug concentration in the heart and CNS (although subsequently 
the drug redistribution takes place). As a rule, drugs are administered 
intravenously slowly. The bolus administration, drop-by-drop 
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administration, and infusion are possible. Non-soluble substances, oil 
solutions, drugs with marked irritating activity, and drugs provoking 
blood clotting or hemolysis are not administered intravenously. 
Intra-arterial route provides the high drug concentration in the 
region receiving blood through this artery. Intra-arterial rout is used 
in treatment of endarteritis and chilblains, for X-ray examination, etc.  
Intraosseous drug administration is used in traumatology for 
regional anaesthesia of extremities, for administration of plasma-
substituting drugs (and even blood) in patients with massive burns, 
including children (administration into the heel bone). The speed of 
drug effect development for intraosseous administration is 
approximately the same as for intravenous route.  
Intracardial route of drug administration is used in case of the 
heart arrest. The aim of this administration is to restore the activity of 
sinoatrial node. Drug injection is accompanied by the following heart 
massage. 
Subarachnoidal route is used for the administration into the 
spinal canal (with piercing meninges) of such drugs as local 
anaesthetics, morphine, some antibiotics (for treatment of 
meningitis). Subarachnoidal injection is performed by an 
experienced surgeon or anaesthesiologist.  
Epidural route provides the drug administration into the spinal 
canal, but dura must not be pierced. This route is used for anaesthesia 
of internal organs of the body regions which are located below the 
level of injection or for pain relief during delivery.  
Intraperitoneal drug administration is used seldom. For example, 
antibiotics may be administered intraperitoneally during the surgery 
on abdominal organs.  
In intramuscular administration, the injection is most commonly 
made into the external outer quadrant of the sciatic muscle. When 
administering oil-based solution or suspension, it is necessary to make 
sure that the needle does not hit a blood vessel. The speed of drug 
absorption may be increased or decreased by using heat or ice pack. 
Subcutaneous route is widely used for administration of different 
drugs, insulin, and vaccines. Subcutaneous injections are painful. 
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The speed of subcutaneous drug absorption is lower than in case of 
intramuscular administration. If intravenous drug administration is 
impossible (e.g., in patients with extensive burns), subcutaneous 
administration is used for elimination of dehydration, disturbances of 
electrolyte balance or acid-base balance, and for parenteral feeding. 
1.5–2 L of fluids may be administered subcutaneously during 
24 hours. The solutions must be isotonic. 
Endolymphatic route provides the drug administration in the 
lymphatic system. As a rule, the drug is administered in lymphatic 
vessels of the rear side of the foot, catheterization of which is 
fulfilled by means of microsurgical techniques. The drug is 
administered through special batcher at 0.3 mL / min flow rate. The 
administered solution must be warm. Endolymphatic route is used in 
diseases which are characterized by active participation of the 
lymphatic system in pathogenesis (e.g., bacterial infections and prior 
the surgery for prevention of purulent complications). 
Inhaled route of drug administration is used for the influence 
upon bronchial smooth muscles in patients with asthma, for 
treatment of purulent infective diseases of bronchi and lungs, 
inflammation of trachea and pharynx, for oxygen therapy, and for 
inhaled narcosis. A drug with airflow is administered into the 
airways by means of inhalers or spray-bottles. The contact between 
inhaled air and blood provides the fast drug absorption. The effect of 
the drug depends on its concentration in the inhaled air.  
Transdermal route of administration is used for providing 
resorptive effects of the drugs with marked lipophilic properties. The 
degree of drug absorption depends on its lipid solubility. The skin 
lesions (maceration, cracks, etc.) increase the absorption speed. The 
ability to be absorbed significantly depends on the properties of the 
ointment base of a drug product. Such ointment bases, as lanoline, 
pig fat, dimethyl sulfoxide, and spermaceti, increase the transdermal 
drug absorption.  Dimethyl sulfoxide also exhibits anti-inflammatory, 
antiallergic, and antibacterial effects. Transdermal medicines provide 
stable drug concentration in the blood for extended time periods. 
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Nowadays, transdermal drug products are becoming more 
widespread. 
Intranasal route is used mainly for treatment of rhinitis. 
Medicinal forms for intranasal administration include the nasal 
drops, ointments, and emulsions. It is necessary to notice that nasal 
mucosa is characterized by significant blood flow and provides the 
high degree of drug absorption.  
Conjunctival route of drug administration is used in treatment of 
glaucoma, conjunctivitis, trachoma, initial stage of cataract, etc. 
Solutions of eye drops, eye ointments, and eye membranes are 
medicinal forms which are used for application into conjunctival sac.  
 
Drug Distribution in Organism 
 
After absorption in the blood, drugs undergo the uneven 
distribution in internal organs and tissues. The tissue barriers 
significantly influence the drug distribution. The tissue barriers 
include the capillary wall, cytoplasmic membrane, the blood-brain 
barrier, and the placental barrier.  
Most drugs easily penetrate through the capillary wall. Some 
drugs penetrate through pores by means of filtration; other drugs 
penetrate through the capillary wall due to diffusion. Some 
hydrophilic agents are transported through the capillary wall by 
means of energy called “active transport”.  
The blood-brain barrier is the significant obstacle for drug 
penetration into the central nervous system. The cerebral capillaries 
have no pores. Pinocytosis also is impossible in them. Besides, the 
external surface of the vascular endothelium is covered by astroglia 
that creates the additional barrier for a drug. In general, hydrophilic 
agents poorly penetrate into the brain, but lipophilic drugs penetrate 
well. The permeability of the blood-brain barrier increases due to 
inflammation of the meninges.  
The placenta is a significant barrier for drug penetration into the 
fetus. But lipophilic and some hydrophilic (ionized) agents penetrate 
through the placenta. 
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After absorption, a significant amount of the drug binds with 
plasma proteins, mainly – with albumins. The high degree of binding 
is typical for sulfonamides of prolonged action, for semisynthetic 
penicillins and for some other antibiotics and anti-inflammatory 
agents, etc. The drugs associated with proteins do not penetrate into 
the tissues, are poorly filtered in kidneys, accumulated in the body, 
and actually lack pharmacological activity. There is dynamic 
equilibrium between free drug fraction and associated part of drug. 
As free fraction penetrates into the tissues, its amount in plasma is 
maintained due to the drug releasing from the associated fraction.  
In intravenous administration, the drug distribution is carried out 
in two steps. Initially, the drug concentration quickly achieves the 
maximal level and drug enters tissues together with intensive blood 
flow (heart, brain, lungs, and kidneys). Figuratively speaking, these 
organs are taking “the first pharmacological blow”. During the 
following 10 minutes after injection, the drug is distributed between 
the blood and the extra vascular fluids and tissues of the body, 
including organs with low intensity of blood flow (muscles, 
subcutaneous fat, etc.). In intramuscular and subcutaneous 
administration, the first phase of drug distribution is weak, because 
the drug absorption from the injection site and its distribution in the 
organism occur simultaneously. 
The following drug distribution depends on its lipophilic or 
hydrophilic properties and affinity to certain tissues. Lipophilic 
agents undergo intensive uptake by fat tissue with depositing in it. 
Drug release from depot depends on drug excretion and reduction of 
its concentration in the blood. Some drugs exhibit selective affinity 
to certain organs and tissues. The drug fraction is released from 
depot and exhibits its pharmacological effects when the blood drug 
concentration becomes quite low.  
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Drug Biotransformation 
 
Most drugs undergo metabolic changes in the organism. This 
process is called “biotransformation”. As a rule, due to metabolic 
changes, the drug is transformed into water-soluble substance which 
is easily excreted with urine, bile, or sweat. Polar metabolites are 
badly dissolved in lipids and characterized by low ability to bind to 
plasma and tissue proteins. Metabolized drugs badly penetrate 
through biological membranes and are not reabsorbed by kidneys and 
intestine.  
Drug biotransformation occurs mainly due to hepatic 
microsomes. Some metabolic changes take place in the intestine, 
lungs, skin, and plasma. Only some drugs are excreted from the body 
in unchanged form.   
There are two main types of drug biotransformation: 
– metabolic transformation;  
– and conjugation.            
Metabolic transformation is the chemical changes of the 
substance due to oxidation, reduction, or hydrolysis.  
Oxidation is one of the most common ways of drug inactivation. 
Oxidation occurs in the liver with participation of microsomal 
enzymes – oxidases. The main representative of oxidases is 
cytochrome P450. Due to oxidation, the hydrogen atoms are cleaved 
from the side chains of drug molecules. NADP and oxygen 
participate in oxidation.  
Reduction is the more rare drug metabolism. Such enzymes as 
nitro- and azoreductases and some others participate in this reaction. 
Reduction is typical for steroid hormones and their analogues. Such 
drugs as chloramphenicol, nitrazepam, chloralhydrate, and some 
others also undergo metabolism by way of reduction.  
Hydrolysis is the way for inactivation of ethers and amides. Due 
to hydrolysis, the ether or amide bond is destroyed. This reaction 
takes place in the presence of water. Enzymes which catalyze 
hydrolysis (esterases) are characterized by substrate specificity. 
Sometimes, the hydrolysis of initially inactive form of drug results in 
formation of a metabolite with certain pharmacological activity. That 
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is, the part of modern angiotensin-converting-enzyme inhibitors is 
prodrugs which are transformed into pharmacologically active agents 
due to hydrolysis (enalapril is transformed into enalaprilate, 
fosinopril – into fosinoprilate, etc.).   
Conjugation is a reaction of accession of hydrophilic 
endogenous metabolite to the drug molecule. Previously, endogenous 
metabolite is activated by formation of macroergic bound at the 
expense of ATP. Typical reactions of conjugation are the drug 
binding to the residues of acetic or glucuronic acids, glutathione, 
sulfates, methyl residue, etc. Conjugation can be the only way of 
drug biotransformation or can occur after previous metabolic 
transformation. As a rule, drugs lose the biological activity due to 
metabolic transformation and conjugation. The drug inactivation is 
significantly slowed down in patients with hepatic pathology (acute 
or chronic hepatitis, cirrhosis, etc.). It results in prolongation of drug 
action and overdose.  
Some drugs inhibit the activity of microsomal hepatic enzymes 
(chloramphenicol, phenylbutazone, etc.) or other enzymes 
(cholinesterase inhibitors, MAO inhibitors, etc.). It causes the 
prolongation of action for drugs which are metabolized by means of 
these enzymes. At the same time, there are drugs which stimulate the 
synthesis of microsomal enzymes: phenobarbital, ethanol, diazepam, 
carbamazepine, rifampicin, etc.  
 
Drug Excretion 
 
Drugs and their metabolites are excreted from the body by 
different ways: together with urine, feces, bile, mother milk, expired 
air; secreted by sweat, bronchial, and sebaceous glands, etc.  
The kidneys play a major role in the drug excretion. The drug 
excretion depends on the processes of filtration, reabsorption, and 
secretion. Such substances as water, glucose, amino acids, proteins 
with molecular weight up to 60,000, and some other substances are 
filtered in the glomerulus of the kidney nephron. Drug molecules that 
bind to plasma proteins are not filtered. The filtration speed depends 
on intensity of renal blood flow. In pathological states with reduced 
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renal blood flow (shock, glomerulonephritis, etc.), filtration is 
significantly reduced.   
Active drug secretion occurs in the proximal convoluted tubules 
of nephrons. Secretion through tubular epithelium into the primary 
urine takes place by means of special transporters with the use of 
energy. Both free fraction of the drug and fraction associated with 
proteins may undergo the secretion.  
Reabsorption of drugs occurs in distal convoluted tubules. 
Because drug reabsorption occurs due to passive diffusion through 
lipid membranes of the epithelial cells, the non-dissociated lipophilic 
molecules of weak acids or bases and neutral substances are 
reabsorbed better. Reabsorption depends on pH of urine. Thus, weak 
acids (barbiturates, benzodiazepines, and sulfonamides) poorly 
dissociate and are easily reabsorbed in blood if pH of urine is acidic. 
On the contrary, molecules of weak bases (morphine, atropine, 
quinine, etc.) dissociate much in the acidic environment and, 
therefore, are poorly reabsorbed and easily excreted from the body.   
Regulation of the urinary pH may be used for treatment of 
patients with drug overdose and poisoning. Thus, alkalization of 
urine by means of sodium hydrocarbonate creates the favorable 
condition for the acceleration of weak acid elimination. And, vice 
versa, acidification of the urine increases alkaloid excretion because 
alkaloids are weak bases.  
It is necessary to notice that excretion of drugs and their 
metabolites is significantly slowed down in patients with renal 
failure. The drugs which undergo mainly hepatic inactivation are 
preferable for treatment of such patients.    
Drugs, which are poorly absorbed in gastrointestinal tract, are 
excreted with feces. Such drugs are used mainly for influence upon 
intestinal microflora or as laxative agents. 
Some drugs (tetracyclines, penicillins, etc.) are excreted with 
bile into small intestine, where they undergo either the excretion with 
feces or secondary intestinal reabsorption (so-called enterohepatic 
recirculation).  
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Volatile substances are excreted from the body through lungs. 
This process occurs due to passive diffusion and depends on 
frequency and depth of respiration.  
Some drugs are excreted with secrets of exocrine glands (sweat, 
salivary, gastric, etc.).  
Some alkaloids are secreted into the stomach cavity, where they 
undergo the secondary absorption in the blood (e.g., morphine). 
Therefore, multiple gastric lavages are necessary in treatment of 
patients poisoned by such alkaloids.  
The drug excretion with mother milk (anticoagulants, 
tranquilizers, cytostatic agents, etc.) is a danger to child.  
The process of clearing the organism from the drug is called 
elimination. For estimation of elimination is used value of “half-life 
of elimination” or “plasma half-life” (T1/2). Half-life of elimination is 
the time during which the drug plasma concentration is decreased 2 
times from its maximum concentration.  
It is necessary to notice that an increase of a drug dose results in 
the lower rate of drug elimination, therefore, the drug’s plasma half-
life increases.   
Besides, the term “clearance” is used for quantitative 
characteristic of the rate of drug elimination. Drug clearance is 
defined as the fixed volume of fluid (containing the drug) cleared of 
drug per unit of time (eg., mL / min, L / h). There are general, renal, 
and hepatic clearances.  
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Drug Pharmacodynamics  
 
Types of Drug Action 
 
Some drugs can act at the place of their application. Such type of 
drug action is called local action. Such medicinal forms as pastes, 
ointments, and compresses act locally. But pure local action is very 
seldom, because some amount of drug is absorbed through skin and 
mucosa into the blood.  
Action of the drug after its absorption into the blood is called 
resorptive action.  
Both in local and in resorptive action, the drug can influence the 
substrate directly (direct action), or indirectly – through another 
organ or system (indirect action).  
Reflex action is an example of indirect action, when the changes 
of activity of neural centers or internal organs develop due to drug 
influence upon some receptors. Thus, the use of mustard plasters, 
irritating skin receptors, results in relaxation of vessels in some 
tissues and in improvement of their trophism.  
The drug action can be nonspecific (general) or specific 
(selective). Drugs with nonspecific action influence the functions of 
many organs and tissues. For example, adaptogens are characterized 
by nonspecific action. The drugs with specific action influence the 
function of certain organ or tissue. For example, aerosol of 
salbutamol influences the bronchial smooth muscles and is used for 
treatment of bronchial asthma. Because the pure selective action is 
practically impossible, the term “selective action” is commonly 
replaced by the term “predominant action”.  
There are main and secondary actions of drugs. The main action 
is a drug action which provides therapeutic effect. For example, 
cardiotonic action of cardiac glycosides upon the heart provides their 
curative effect in treatment of patients with chronic and acute heart 
failure. Simultaneously, cardiac glycosides improve renal blood 
flow. It is an example of secondary action of cardiac glycosides. 
Depending on the strength of the bond between the drug and 
receptor, there are reversible and irreversible actions. In case of 
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reversible action, the function of the target organ (tissue, enzyme, 
etc.) is restored after certain period of time. Reversible action is 
typical for cholinesterase inhibitors with reversible action 
(proserinum, etc.). Drugs with irreversible action exhibit the stable 
effect, when the function of the target organ is restored during long 
time or is never restored. Irreversible action is typical for organic 
phosphorus compounds, blocking acetylcholinesterase in cholinergic 
synapses.  
The pharmacological effect develops due to interaction of a drug 
with certain receptors. Receptors are macromolecules which can 
interact with the drug with the following change in the cellular 
activity. There is a large number of different receptors: cholinergic, 
adrenergic, dopaminergic, serotoninergic, and other receptors.  
The ability of the drug to bind to the receptor, which determines 
the formation of the “drug-receptor” complex, is called affinity.    
A drug is called an agonist (mimetic) if its interaction with 
receptors results in certain biological effects. As a rule, these 
biological effects are stimulating. If due to interaction with the 
receptor the drug produces a maximal effect, this drug is called a full 
agonist. A drug producing a partial effect is called a partial agonist.  
A drug is called an antagonist (blockering drug) if its 
interaction with receptors does not result in changes which are 
typical for stimulation of these receptors.  
A drug influencing upon one subtype of receptors as an agonist 
and upon another subtype as an antagonist is called an agonist-
antagonist. For example, nalorphine is an agonist of - and -opioid 
receptors and an antagonist of -receptors.  
 
Principles of Drug Dosing  
 
 The drug action depends on the dose. A dose is the quantity of 
the drug which is taken by a patient. A quantity of the drug for the 
one intake is called the single dose. A quantity of the drug which is 
taken by patient during a day is called the daily dose. A course dose 
is the quantity of the drug which is needed for the full course of 
treatment.  
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The minimal drug quantity which causes the development of the 
minimal therapeutic effect, is called a minimal therapeutic dose. 
However, the minimal therapeutic doses are seldom used in 
medicine. Usually, clinicians are guided by moderate therapeutic 
doses. A moderate therapeutic dose is the drug quantity which causes 
the development of the optimal therapeutic effect in most patients. 
Sometimes, the highest therapeutic dose of dose is prescribed. A 
highest therapeutic dose is the greatest quantity of drug, the intake of 
which does not cause the development of toxic effects. After the 
range of therapeutic doses, there is the range of toxic doses which is 
replaced by the range of lethal doses. Accordingly, the minimal, 
moderate, and highest doses are distinguished in the each dose range.  
The maximum therapeutic doses (both single and daily) of 
strongly-acting and poisonous drugs are given in the State 
Pharmacopoeia of Ukraine. Recommended moderate therapeutic 
doses for adults and children are the landmarks in clinicians’ work. 
During the treatment, a clinician corrects the prescribed doses in 
dependence on the severity of the patient’s condition, dynamics of 
change in symptoms, and patient’s sensitivity.  
In cases when it is necessary to create the high drug 
concentration in the human organism, the first dose of the prescribed 
drug may be higher than the subsequent doses. This dose is called a 
loading dose. The subsequent doses which are used for continuation 
of treatment are called maintenance doses.  
Besides curative doses, the preventive doses are widely used in 
medicine in cases when it is necessary to prescribe some drugs for 
prevention of certain diseases.  
The term “breadth of therapeutic action” is closely connected 
with the term “dose”. The breadth of therapeutic action is the range 
from the minimal therapeutic dose to the maximal therapeutic dose 
inclusive. The broader is therapeutic action, the greater is safety of 
the drug that provides for clinician the higher ability to choose the 
optimal therapeutic dose for a patient.  
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Also, the term “therapeutic index” is used to define the drug 
safety. Therapeutic index is the ratio of moderate lethal dose (LD50) 
to moderate therapeutic dose (ED50) in animal studies: 
 
Therapeutic index = LD50 / ED50, 
 
where LD50 is a dose that causes the death of 50 % of experimental 
animals and ED50 is a dose causing the pharmacological effect in 
50 % of animals. The larger the therapeutic index, the safer the drug 
is.  
A physician should always remember the Arndt-Schulz rule 
formulated by Hugo Paul Friedrich Schulz and Rudolf Arndt. It 
states that for every substance, small doses stimulate, moderate doses 
inhibit, and large doses kill. That is, small doses stimulate the 
functions of vital elements, moderate doses increase them, high doses 
inhibit the functions, and excessive doses paralyze them.  
 
Phenomena Occurring due to Repeated Drug Administration 
          
 The repeated drug administration can result in both the increase 
and the decrease of the drug effect. An increase in effectiveness of 
the drug is the result of drug ability to accumulate in the body. This 
phenomenon is called cumulation.  
There are both material and functional cumulation. Material 
cumulation is the accumulation of drug itself in the body. It is 
determined by the delay in drug biotransformation and its slow 
excretion. A possibility of cumulation arises when the drug binds to 
some substrates and undergoes slow metabolism. Cumulation can 
cause intoxication. The high degree of cumulation is typical for 
cardiac glycosides, indirect anticoagulants, hypnotic drugs, etc.  
Functional cumulation is the accumulation of drug effects. A 
prominent example of functional cumulation is a phenomenon of 
alcoholism. In alcoholism, the pathological psychical changes due to 
alcohol abuse, gradually increase up to the development of the acute 
alcoholic psychosis (delirium tremens). Ethyl alcohol itself does not 
accumulate in the body due to repeated drinking, because it 
undergoes fast metabolism and excretion.  
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For prevention of drug cumulation, the close control of the 
dynamics of functional changes in the body and the drug dosage 
regime correlation are necessary.  
Tolerance is another phenomenon which can develop due to 
repeated drug intake. Tolerance is the gradual reduction of drug 
efficacy due to repeated intake. The following tolerance causes are 
possible: reduction of drug absorption, decrease of receptor 
sensitivity to the drug, activation of additional metabolic ways 
instead of those blocked by the drug, acceleration of drug 
biotransformation (due to induction of microsomal enzymes), rate 
increase of drug excretion from the body, amplification of 
homeostatic regulatory mechanisms, etc. If tolerance has developed, 
the increase of drug dose is necessary for achievement of initial drug 
effect. Also, it is possible to replace used drug by other medications. 
But it is necessary to notice, that cross-tolerance is also possible. In 
this case, tolerance extends to other drugs with similar chemical 
structure or mechanism of action.  
Tachyphylaxis is a special kind of tolerance. It is a very fast 
tolerance (sometimes after simple drug intake). As a rule, 
tachyphylaxis develops owing to substrate exhaustion. For example, 
repeated ephedrine administration causes less elevation in blood 
pressure if drug is administered repeatedly, with interval 10–30 
minutes. It is due to reduction of noradrenaline storage in adrenergic 
synapses.    
In case of sudden discontinuation of drug administration, the 
withdrawal (or discontinuation) syndrome can develop. There are 
two types of the withdrawal syndrome. The first type is typical for a 
long-term use of hormonal agents. Its essence is in the inhibition of 
appropriate endocrine glands. Particularly, this type of the 
withdrawal syndrome is typical for glucocorticoids (prednisolone, 
dexamethasone, etc.). According to negative feedback, a therapy 
with glucocorticoids results in the adrenal gland atrophy and 
reduction of endogenous glucocorticoid synthesis. After cessation of 
glucocorticoid therapy, the restoration of adrenal gland activity lasts 
from several months to a year or more. Therefore, sudden 
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glucocorticoid therapy discontinuation is accompanied by acute 
adrenal insufficiency with shock-like symptoms. An administration 
of hormonal drugs is necessary for elimination of these symptoms. 
To prevent the discontinuation syndrome, the glucocorticoid removal 
should be slow, with gradual reduction of the dose and frequency of 
drug administration.  
The second type of the withdrawal syndrome develops when the 
sudden cessation of the drug intake is accompanied by the 
development of the rebound syndrome. The essence of this 
phenomenon lies in the fact that cessation of drug intake is 
accompanied by disinhibition of the regulatory processes which were 
inhibited by the drug. A hypercompensation with acute aggravation 
of the main disease develops in this case. To prevent the rebound 
syndrome, the phasing out of the drug is used when both the dose 
and the frequency of the drug administration are gradually decreased. 
Some drugs cause the development of the drug dependence due 
to repeated intake. There are psychical and physical drug 
dependences. Psychical drug dependence is manifested by changes in 
the patient’s mind with the following desire to take the drug 
repeatedly. Psychical dependence develops due to the use of 
psychosedative drugs which create the feeling of mental comfort, 
sedation, relaxation, fast and easy way to fall asleep, and imaginary 
elimination of life conflicts. A rejection of such drugs is 
accompanied by discomfort, psychical tension, fear, anxiety, 
uncertainty, etc. A desire to get rid of these feelings makes an 
addicted person to take drugs again and again. Furthermore, the 
taken dose should be constantly increased owing to the development 
of tolerance.  
Psychical dependence in people develops also to drugs with 
stimulating action (amphetamine, sydnocarbum, caffeine, etc.). 
These drugs cause feeling of tidal forces, activity, euphoria, 
overestimation of their own capabilities, etc. A desire to keep this 
condition makes people take psychostimulants. A cessation of such 
drug use is accompanied by depression, mood decline, reduction of 
capacity to work, etc. Such dependence is called toxicomania.  
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Physical drug dependence develops due to metabolic 
restructuring in the organism under the influence of certain drug. 
That is to say, such drug became essential for function of some 
organs and systems. The physical dependence is more severe 
substance dependence. It develops due to the use of opioid analgesics 
(morphine, promedolum, heroin, etc.), hypnotic drugs, and some 
other drug groups.  
In persons with physical dependence, a cessation of drug intake 
causes severe conditions with functional disturbances of different 
organs and systems (convulsions, loss of consciousness, abdominal 
pain, nausea, vomiting, respiratory depression, etc.) and even death 
in patients. A complex of these symptoms is called a withdrawal 
syndrome or abstinence. Addiction consequences are well known to 
everybody: the development of drug trafficking, personality 
destruction, spreading of AIDS, hepatitis, etc.  
 
Combined Drug Use 
 
With an aim to reach the best therapeutic result, the combination 
of several drugs is commonly used in medicine to influence different 
links of pathological process. But it is necessary to notice that such 
combined therapy can cause various complications. According to 
statistics, the quantity of pharmacotherapeutic complications 
increases proportionally to the amount of the used drugs. To avoid 
possible complications, a clinician should know peculiarities of drug 
interactions.  
Drug interactions can change both pharmacokinetics and 
pharmacodynamics of one another. There is the following 
classification of drug interactions:  
1. Pharmacological interaction: 
1.1. Pharmacokinetic interaction. 
1.2. Pharmacodynamic interaction.  
1.3. Physico-chemical interaction in the body. 
2. Pharmaceutical interaction.       
Pharmacokinetic interaction develops during the use of two or 
more drugs. Drugs can influence one another at the stages of 
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absorption, biotransformation, transport, deposition, and excretion 
from the body.  
Thus, intake of absorbents (active carbon) or covering agents 
(Almagel) worsens the absorption of other drugs.  
If taken drugs interact with plasma proteins, the one drug can 
replace another in the binding to proteins that results in an elevation 
of the free fraction of the second agent. It can cause toxic effects. 
Medications can interact at the biotransformation step. Thus, a 
use of drugs stimulating activity of hepatic microsomal enzymes 
(phenobarbital, etc.) can minimize the efficacy of other drugs due to 
activation of their biotransformation. 
In case of pharmacodynamic type, the drugs interact on the 
level of receptors. An unidirectional effect of two or more drugs is 
called synergism. There are two main types of synergism: summation 
and potentiation. In case of summation, the final effect of both drugs 
is equal to the sum of their individual effects (additive effect, by 
analogy with arithmetic: 2 + 4 = 6). When final effect of two or 
several drugs is more than arithmetic sum of their individual effects, 
such type of synergism is called potentiation (supra-additive effect: 
2 + 4 → 10). Potentiation is more profitable type of synergism. Also, 
it is possible a variant when final effect is less than arithmetic sum of 
individual effects of drugs, but more than individual effects of every 
single drug. It is so-called infra-additive effect (2 + 4 → 5). 
Synergism is widely used in therapy to achieve the necessary 
effect by enabling the dose of each of the combined drugs to 
decrease. Unfortunately, synergism is evident not only for 
therapeutic effects but also for toxic effects.  
Drug interaction can be accompanied by reduction of their 
efficacy. This phenomenon is called antagonism. Like synergism, 
there are direct and indirect types of antagonism. If two antagonizing 
drugs influence the same substrate, such antagonism is called direct 
(e.g., adrenomimetics and adrenoblockering drugs). If one drug 
inhibits the effect of another but these drugs influence the different 
substrates, their antagonism is indirect (e.g., the influence of 
adrenomimetics and cholinomimetics upon the heart).  
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Besides, there is phenomenon of synergo-antagonism, when 
some effects of simultaneously used drugs are increased, but other 
effects are reduced.   
Chemical and physicochemical interactions of drugs are 
possible in human organism. Thus, charged negatively molecules of 
heparin interact with positively charged molecules of protamine 
sulfate. 
Antagonism is widely used in medicine for reduction of drug 
side effects and for treatment of acute poisonings. In such cases we 
say about antidotes. 
Although a combined use of drugs is widely used in medicine, 
an advantage should be given for monotherapy (treatment by one 
drug) because side effects of a simple drug are more easily 
predictable and controllable.  
Pharmaceutical interaction is possible during processes of drug 
manufacturing and keeping or due to mixing drugs in one syringe. 
For example, the mixed in syringe dibazolum with papaverine reduce 
the effects one of another. A base for pharmaceutical incompatibility 
of drugs is their chemical and physical properties.         
 
Main Types of Pharmacological Therapy 
 
Etiotropic therapy is an ideal type of pharmacotherapy because 
suggests the influence upon the disease cause. An example of 
etiotropic therapy is the antibiotic use for treatment of infections. But 
it is necessary to notice that there is the limited list of drugs which 
affect the disease cause. 
A main direction of modern pharmacotherapy is the use of 
drugs influencing upon basic (possibly the initial) mechanisms of 
disease pathogenesis. It is so-called pathogenetic therapy. A 
substitutive therapy is the species of pathogenetic pharmacotherapy 
when certain drugs are prescribed for deficit compensation of 
corresponding metabolites, enzymes, hormones, vitamins, etc.  
Symptomatic therapy is the use of drugs which reduce or 
eliminate certain disease symptoms (e.g., pain). Although 
symptomatic therapy does not result in the recovery, this type of 
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pharmacotherapy is very important and useful (e.g., the use of 
analgesics in traumas).   
Preventive therapy is also important because it is used to 
prevent certain disease. Thus, antiviral drugs are used with the 
purpose of preventing epidemics, antiplatelets are used after 
myocardial infarction with the purpose to prevent platelets 
aggregation, etc. Preventive therapy is the therapy of future.  
 
Factors Influencing Drug Effects  
 
Age value. Moderate and highest therapeutic doses are 
prescribed to adults aged from 18 to 60 years. As a rule, a size, 
weight, and other individual peculiarities of a person are not taken 
into account. For patients with low stature and for exhausted patients, 
the doses are decreased. Sometimes, the drug dosage is performed 
for 1 kg of the patient’s weight or for the unit of the body surface 
area. 
Pediatric pharmacology studies the peculiarities of drug action 
upon the child's body. The less is the child’s age, less perfect are his 
neuronal and humoral regulatory mechanisms, systems of drug 
inactivation, immunity, etc. Such organism peculiarities influence the 
health, growth, and development of the child.  
Perinatal pharmacology is the special section of pediatric 
pharmacology. Perinatal pharmacology studies the drug influence 
upon the fetus from 24 weeks up to labor and upon the newborn up 
to 4 weeks. The fetus and newborns are especially sensitive to drug 
action. It is due to the following peculiarities of their organism: low 
activity of enzymes, which metabolize the drugs, or absence of these 
enzymes, reduced excretory renal function, increased permeability of 
the blood-brain barrier, and underdeveloped central nervous system. 
Microsomal enzyme system of the liver is formed in the newborn up 
to the end of the second week, but the full development is reached 
only up to the end of pubescence. Thus, chloramphenicol, antibiotic 
drug, is very toxic for newborns and can cause their death because 
their liver lacks the enzymes which are essential for inactivation of 
this agent.  
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State Pharmacopoeia contains the highest simple and daily 
doses of poisoning and powerful drugs that are prescribed to children 
of different age. Dose calculation for drugs which are absent in 
Pharmacopoeia is fulfilled according to the following rule: 1/20 part 
of the adult’s dosage is taken for each year of the child’s age. It is 
necessary to notice that such calculations are very approximate 
because some children, in their weight and stature, may lag behind in 
development at 1–2 years of age. 
Geriatric pharmacology studies the reaction peculiarities of old 
and senile patients to the medications. As a rule, such patients have 
not only age changes but also several chronic diseases. In such 
patients, absorption and excretion of drug slows down owing to 
worsened blood supply of gastrointestinal tract and kidneys. Hepatic 
drug biotransformation is slowed; the level of blood proteins is 
reduced. The body water is decreased, and the fat tissue volume is 
increased with age. In old age, the adaptive reserves of human 
organism are sharply reduced; the carbohydrate assimilation is 
impaired; and the risk of thrombosis, hypoxia, and acidosis is 
increased. Age-related changes in vascular wall result in the 
decreased blood flow: cerebral and coronary blood supply is 
especially reduced. Therefore, for patients after 60 years of age, the 
doses of most drugs should be decreased by 1/3–1/2 of the adult 
treatment dose. Even with these amendments, the drug toxicity in 
elderly patients significantly higher than in middle-aged people. 
Therefore, if it is possible, herbal medicines and other safe drugs 
should be used for treatment of elderly patients.  
Patient status. Different diseases significantly influence the 
sensitivity to drugs and their efficacy. Renal and hepatic diseases can 
cause the retardation of active drug elimination from the organism 
that increases the complication risks.  For their prevention, it is 
necessary to know the main ways of drug inactivation. Thus, in 
patients with renal insufficiency, the use of drugs which are 
inactivated in liver is preferable; in patients with hepatic diseases, 
preference is given to drugs which are excreted mainly in unchanged 
form through the kidneys. A frequency of drug complications and 
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intoxications is higher in dehydrated, exhausted patients and at 
weakeneds. Sometimes, the sensitivity to drugs is changed owing to 
certain pathology. Thus, hyperthyreosis is accompanied by the 
increased sensitivity of myocardium to catecholamines. Also, human 
organism sensitivity to drugs changes during pregnancy, menopause, 
etc.  
Gender value. Gender-linked differences in pharmacological 
response have been investigated insufficiently. In comparison with 
male, female organism is more sensitive to some substances and 
drugs (nicotine, alcohol, strychnine, hormonal agents, psychotropic 
drugs, etc.). But, sensitivity of female organism to cardiovascular 
drugs is less than the male organism. Males need higher doses of 
analgesics for postoperative pain relief. Often, pharmacotherapy in 
women should be stopped during menses and for several following 
days.  
Value of genetic factors. Pharmacogenetics studies the 
hereditary influence on the reactivity of human organism to drugs 
and other xenobiotics. It is known that some toxic effects of drugs 
are caused by blockage or absence of certain genes responsible for 
synthesis of some enzymes metabolizing xenobiotics. Thus, duration 
of dithylinum action sharply increases (up to 6–8 hours instead of 5–
7 minutes) due to hereditary insufficiency of plasma 
pseudocholinesterase (butyrylcholinesterase). Erythrocyte glucose-6-
phosphate dehydrogenase deficiency is widely spread in regions 
where population suffer from malaria for many centuries. This 
enzyme deficiency causes erythrocyte hemolysis after intake of 
certain drugs (acetylsalicylic acid, paracetamol, chloramphenicol, 
amidopyrine, sulfonamides, nitrofurans, etc.). Such abnormal 
individual response to a drug due to a genetic anomaly is called drug 
idiosyncrasy. It develops on the first administration of the drug, even 
in small doses. As a rule, idiosyncrasy manifests by sharp and 
turbulent development. Idiosyncrasy can be identified by collecting 
family history and survey information of the patient’s tolerability of 
drugs in the past.  When prescribing new drugs, it is necessary to 
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control the reaction on the first administration of the drug (especially 
in childhood).  
Value of daily rhythms. A value of daily rhythms has an 
undoubted importance for the physiological state of the organism. In 
the waking state, the activity of nervous and endocrine systems is 
significantly higher than during the sleep. It is reflected in the 
susceptibility of the organism to different drugs. Chronopharmacology 
studies the influence of daily rhythms on the organism. 
Chronopharmacology is divided into chronopharmacokinetics and 
chrono-pharmacodynamics.  
It is proved that the maximum effect of drugs is observed during 
the period of the maximum human activity, that is, in the daytime. 
Thus, maximum analgesic effect of morphine is produced at the 
beginning of the second half of the day. In the morning and in the 
night, the morphine activity is significantly less. During angina 
attacks, nitroglycerin efficacy is significantly higher in the morning 
than during the second half of the day. The drug toxicity also changes 
in dependence of the day time. Absorption, biotransformation, and 
other pharmacological peculiarities of drugs can change during the 
day. It is known, that antimycotic agent griseofulvin is absorbed better 
at noon. Absorption of lithium carbonate is significantly higher in the 
daytime than during the night. One should remember that the drug 
pharmacological effects produced by drugs at certain times of the day 
can depend on certain pathological states of the organism. Besides the 
daily rhythms, there are seasonal rhythms – physiological functions of 
the organism which also influence the drug activity. 
 
Main and Side Drug Effects  
 
The drug action which provides the development of necessary 
pharmacological effect (blood pressure reduction, pain relief, fewer 
reduction, etc.) is called main action. However, besides the main 
effects, all drugs exhibit side effects which are undesirable for the 
organism. Side effects develop in the range of therapeutic drug doses. 
Thus, a hypnotic agent chloral hydrate significantly irritates the 
mucous membranes when used in therapeutic doses. Side effects may 
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be primary and secondary. Primary side effects arise as a direct result 
of the drug influence on a certain substrate. That is, nausea and 
vomiting induced by ether inhalation develop due to irritative action of 
ether on gastric mucosa. Secondary side effects develop indirectly. 
Thus, severe destructive pneumonia can develop due to aspiration of 
vomit into the respiratory tract during ether narcosis.  
Side effects have different levels of severity and different  
degrees of undesirable influence upon organs and systems.  
Allergic reactions are among the undesirable side effects. Drugs 
can serve as allergens (antigens). According to clinical manifestations, 
there are allergic reactions of immediate and delayed types. Both types 
depend on sensitization of the organism and changes of cellular and 
humoral immunity. 
Idiosyncrasy is also one of clinical manifestations of drug side 
effects.  
Undesirable effects which arise in the range of toxic doses are 
called toxic effects. The main cause of toxic effects is drug overdose.  
Different medications can exhibit an undesirable influence on the 
fetus. Embryotoxic effect develops during first 12 weeks after 
fertilization and, as a rule, results in the fetus death. Embryotoxic 
effect is typical for nicotine, fluor-containing drugs, hormonal drugs 
(estrogens, progestins, desoxycorticosterone acetate, somatotropin, 
etc.), barbituric acid derivatives, antimetabolites, etc.  
Teratogenic action can develop due to the drug influence on the 
fetus from the end of the 4th week up to the end of the 10th week. 
Teratogenic action is manifested by disturbances of tissue 
differentiation that results in the development of the newborn 
abnormalities (malformations). For example, intake of hypnotic agent 
thalidomide by European pregnant women has resulted in the birth of 
more than 5,000 children with phocomelia (malformation of the 
limbs), gastrointestinal and genitourinary tract disorders, etc.  
Fetotoxic effect is the result of undesirable effects of the drug on 
the fetus during the later stages of pregnancy. Herewith, a quality of 
fetus reaction is virtually identical to the reaction of an adult and can 
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cause the development of severe pathology or death of either a fetus or 
a newborn. 
It is necessary to notice that drugs can influence the fetus even on 
the step of progenesis by affecting the reproduction and trophism of 
male and female sex cells and by causing the chromosomal aberrations 
or gene mutations. Such drug ability to cause the stable damages of 
cells and their genetic apparatus which is accompanied by genotype 
change in the child is called mutagenic action. Thereby, it is 
necessary to stop taking any drugs at least 6 month before the planned 
pregnancy.  
Cancerogenic action is the substance ability to cause the 
development of malignant tumors. Cancerogenic action of drugs can 
occur in people of any age.   
Besides mentioned disturbances, the so-called non-physiological 
deviations from the norm are possible due to drug undesirable action 
(e.g., level elevation of uric acid, bilirubin, metabolic acidosis, etc.). It 
provides the conditions for the development of certain diseases.     
 
GENERAL PRINCIPLES OF TREATMENT  
OF ACUTE POISONING  
 
According to statistics, acute poisonings are about 40 % of 
general amount of emergency cases in clinics. Urgent care in 
intensive care unit was necessary for 25 % of them. Mortality from 
acute poisonings is about 4 %. 
Maximum cases of poisonings (accidental poisoning) occur in 
children aged from 1 to 4 years.  Among adults, there are both 
accidental and deliberate (suicidal) poisonings. Moreover, suicidal 
poisonings are common among young people aged from 16 to 20 
years and among elderly. The poisonings caused by alcohol, 
medicines (hypnotic drugs, antihypertensive drugs, etc.), and 
household chemicals (insecticides, dyes, gasoline, kerosene, 
antifreeze, etc.) are dominant. During summer, the poisonings caused 
by such plants as belladonna, Crow's eye, jimsonweed, and 
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mushrooms (especially, by Amanita phalloides) are common. The 
incidents of substance dependence are widespread among teenagers 
inhaling insecticides (Chlorophos [Metrifonate], Carbophos 
[Malathion], etc.), gasoline, kerosene, etc. It is commonly 
accompanied by severe poisonings with fatalities. It is necessary to 
notice that poisons containing toluene cause the condition which is 
similar to action of hallucinogen LSD (lysergic acid diethylamide). 
Such substances can cause psychical dependence with fast 
personality degradation.  
There are acute and chronic poisonings. The chronic poisonings 
develop due to repeated intake of small doses of toxic substances and 
are characterized by slow progressive development of symptoms. A 
majority of professional diseases caused by toxic substances are 
chronic poisonings.  
Acute poisonings are characterized by sharp onset and fast 
development (from several hours to several days). In some cases, 
such poisonings result in the death of a patient. Patients with 
hyperacute poisonings are isolated when symptoms increase 
extremely rapidly with the fast death of the patient. For example, a 
person dies in 15 minutes after parathion intake on an empty 
stomach.  
A treatment of acute poisonings includes the following 
measures:  
– poison elimination from the body; 
– poison inactivation;  
– symptomatic therapy (maintenance of organism functions).  
 
Elimination of Poison from the Body 
Elimination of Unabsorbed Poison 
 
After skin contact with poison drops, it is necessary to rinse 
soap from the skin with warm water. There are specific antidotes 
which neutralize the poison or interfere with its influence upon the 
skin. If poison gets on the conjunctiva or cornea of the eye, it is 
necessary to rinse them with warm normal saline, milk, or water 
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during 10–15 minutes. After this, 0.5–1 % dicainum (tetracaine) 
solution is applied into the conjunctival sack. If phosphorus organic 
compounds get in the eyes, they should be rinsed with 3 % sodium 
hydrocarbonate solution.  
In cases when solutions of acids or alkalis get in the eye, the 
washing of the eye by acidic or alkaline solutions is contraindicated 
due to possibility of eye tissue damage. Such victims should be taken 
to the ophthalmologist. 
In case of snake bite, the cold is applied topically during 6–8 
hours. Circulatory procaine blockage is fulfilled above the bite.  
Gastric lavage or induced vomiting is used for the poison 
elimination from the stomach. 5–10 % sodium chloride solution is 
used (2–4 teaspoon of sodium chloride dissolved in a glass of water) 
for inducing vomiting. This solution irritates the gastric mucosa 
accompanied by spasm of pyloric sphincter and the movement delay 
of poison into intestine. It results in the reduction of poison 
absorption. Ipecacuanha syrup may be prescribed for children. This 
syrup induces the vomiting in 5–20 minutes after intake. Also, 
apomorphine may be administered subcutaneously or 
intramuscularly to adults or children over 5 years of age. 
Simultaneously, ephedrine is administered intramuscularly to prevent 
hypotension.  
Inducing vomiting is contraindicated in the following cases: 
– in unconscious patients (vomit can get into the respiratory 
ways and provoke its obstruction or aspiration pneumonia, because 
such patients have the relaxed epiglottis); 
– in patients poisoned by gasoline, kerosene, turpentine, acids, 
alkalis, phenol, and other substances which irritate mucous 
membranes (during vomiting the drops of these substances can get 
into respiratory tract and cause its damage and pneumonia that can 
result in the death of the patient).   
In other cases, gastric lavage should be fulfilled even after 
vomiting. Gastric lavage is fulfilled several times with interval 3–4 
hours until complete purification of stomach from poison. To prevent 
32 
 
body hypothermia, the warm water or solutions are used for gastric 
lavage. The use of normal saline, Rheopolyglucin, or potassium 
permanganate for gastric lavage is preferable. If necessary, active 
carbon or other adsorbents may be added to the mentioned solutions. 
Also, milk or egg protein solution (12 egg whites in 1 L of boiled 
water) may be used. But use of milk is contraindicated in poisonings 
caused by lipid-soluble substances, because butterfat facilitates the 
poison absorption, relaxes pyloric sphincter, and promotes the poison 
transition into the intestine.  
Some poisons can be secreted from the blood into the stomach, 
with the following repeated absorption in the blood. It provides the 
high concentration of poison in the blood during long time. In such 
cases, gastric lavage is fulfilled 3–4 times and more during 2 days 
(e.g., morphine and noxyron poisonings, etc.). After gastric lavage, it 
is necessary to prescribe active carbon or any other absorbent which 
sorbs the poison residue.  
In cases of lipid-soluble poisoning, vaseline oil should be 
administered (3 mL/1 kg of the patient’s weight) before gastric 
lavage. Also, saline laxative drug is prescribed, and the intestine 
lavage is fulfilled. Saline laxatives (magnesium sulfate or sodium 
sulfate) clean both small and large intestines. Vaseline oil dissolves 
lipid soluble poisons (kerosene, turpentine, gasoline, etc.) but does 
not promote their absorption.   
Also, the siphon enemas are used for elimination of poisons 
from intestine. For siphon enema, 8–10 L of water is used.  
 
Elimination of Poison from Blood 
 
Before elimination of poison from the blood, it is necessary to 
provide a patient with fresh air and administration of analeptics 
(caffeine, aethymizole), or carbogen inspiration. In poisonings 
caused by irritative substances for prevention of pulmonary edema, a 
patient should avoid doing sharp movements. Such patients should 
be warmed and receive inhaled oxygen. For moistening, oxygen is 
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passed through the water in Bobrov’s apparatus. The anti-foaming 
agents (ethyl alcohol or antifomsilan) are administered to the patient 
when the symptoms of pulmonary edema develop. After that, 
measures to eliminate poison from the blood are carried out: forced 
diuresis, hemodialysis, hemosorption, blood replacement, etc.   
Forced diuresis is used for elimination of water-soluble poisons 
and their metabolites from the blood. It is possible if poisons are 
badly bind to proteins and lipids in the blood.  
Technique of forced diuresis depends on poisoning severity. In 
mild poisoning, a patient receives a large volume of drinking water 
and furosemide perorally. The patient should drink the necessary 
water volume during 8–12 hours. The volume of drinking water 
should be at least of daily water demand. In case of average 
poisoning, drugs which are able to bind poisoning are administered 
intravenously (Neohemodesum, Polyglucinum, Reopolyglucinum, 
etc.). In case of acid poisoning (barbiturates, acetic acid, salicylic 
acid derivatives, etc.), 2–4 % solution of sodium hydrocarbonate is 
also administered intravenously. After that, 10 % glucose solution 
with potassium chloride is administered intravenously. In severe 
cases of poisoning, Neohemodesum, Reopolyglucinum, and sodium 
hydrocarbonate solution are administered during 1 hour. After this, 
osmotic diuretics (mannitol) or loop diuretics (furosemide) are 
administered. A volume of fluids administered intravenously should 
be equal to the volume of excreted urine. In case of super-severe 
(terminal) poisoning, initially, it is necessary to restore the breathing 
and the blood circulation. After that, forced diuresis is carried out. 
Forced diuresis is contraindicated in patients with acute and 
chronic cardiovascular failure and patients with disturbances of 
excretory renal function. Forced diuresis efficacy is reduced in 
patients over 50 years of age. 
Blood substitution is effective when a volume of transfused 
blood is 1.5–2 times more than a volume of patient’s blood. To 
prevent hypocalcemia, 10 mL of 10 % calcium chloride solution is 
added to each 500 mL of citrated blood. Blood substitution is 
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effective if it is carried out during the first hours of poisoning. As a 
rule, this measure is ineffective if carried out 8–29 hours after 
poisoning.  
Peritoneal dialysis is based on the ability to transport poison 
from the organism into peritoneal fluid which is located in the 
abdominal cavity. For peritoneal dialysis, Ringer solution is used 
together with added glucose and 5 % albumin solution. Sodium 
hydrocarbonate solution is added in cases of poisoning by acidic 
compounds. Administered into abdominal cavity, the solution is left 
for 45–60 minutes. After that, the solution is evacuated with 
registration of both input and evacuated volumes. Antibiotics are 
added to the fluid to prevent infection. 
Hemodialysis is used for cases of poisoning by substances 
which do not bind to plasma proteins and in development of acute 
renal failure. The earlier you start hemodialysis, the better is a chance 
for success. 
Hemoperfusion is a method of filtering the blood when the 
blood passes throug a column with absorbtive properties aiming at 
removing specific toxic substances from the blood. The adsorbent 
substances most commonly used in hemoperfusion are resins and 
activated carbon. Hemoperfusion is an extracorporal form of 
treatment because the blood is pumped through a device outside the 
patient’s body. By means of hemoperfusion, not only the poisons that 
do not bind to plasma proteins but also other poisons may be 
eliminated from the body.     
 
Inactivation of Toxic Substance 
 
When the toxic substance is known, antidotes are used in the 
treatment of poisoning. Antidotes are drugs which are used in 
specific treatment of poisoning. There are 3 groups of antidotes:  
1) antidotes which bind poison and prevent the absorption of 
poison by their presence;  
2) antidotes which accelerate the poison biotransformation;  
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3) antidotes which are pharmacological antagonists. 
   
Antidotes Binding to the Poison and Facilitating Its 
Excretion from the Body 
 
     Unithiol is a representative of this group. This drug binds 
heavy metals (copper, zinc, bismuth, gold, nickel, chromium, etc.), 
arsenic, and cardiac glycosides. Formed complexes are easily soluble 
in water, and therefore quickly excreted through the kidneys. It is 
necessary to notice that coordination complexes of unithiol with such 
metals as iron, silver, lead, and cadmium are unstable and undergo 
fast hydrolysis. Therefore, in cases of poisoning by these metals, 
unithiol is not used. Unithiol is administered intramuscularly, 
sometimes orally, or in inhalations. Complexes of Unithiol with 
metals undergo dissociation in acidic environment that can cause 
damage of renal tissues. To prevent that, sodium hydrocarbonate is 
used after unithiol administration. Side effects of unithiol are 
dyspepsia, headache, and burning mouth syndrome. Convulsions can 
develop due to unithiol overdose.  
Succimer binds heavy metals, arsenic, and cardiac glycosides. 
The drug is taken orally, administered intramuscularly, or used for 
inhalations. In severe poisoning, 3–4 mL of 5 % succimer solution is 
administered intramuscularly.  
Tetacinum-calcium (in Ukraine) (Edetate Calcium Disodium) is 
a chelating agent which interacts with many metals: lead, iron, zinc, 
copper, chromium, uranium, manganese, vanadium, cesium, etc. 
Most commonly, Tetacinum-calcium is used in treatment of acute 
and chronic lead poisoning. The drug is administered 
intramuscularly, taken orally, or applied locally. For peroral intake, 
Tetacinum-calcium is prescribed only after poison elimination from 
the stomach, because its complexes with metals can be easily 
absorbed. Long-time use of Tetacinum-calcium can result in iron 
deficiency and hypochromic anemia. This drug is contraindicated in 
renal failure and hepatic disturbances.  
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Penicillamin is a derivative of penicillin. Penicillamin is used for 
treatment of copper and lead poisoning.  
Pentacinum is a drug which is used for elimination of 
radioactive lead, cesium, zinc, tritium, and decomposition products 
of uranium. Pentacinum is administered intravenously slowly. 
Methylene blue transforms about 10 % of hemoglobin into 
methemoglobin. The drug is used for treatment of cases with 
poisoning by cyanides, naphthalene, hydrogen sulfide, sulfonamides, 
etc. Cyanides bind to methemoglobin forming of nontoxic 
metcyanohemoglobin that is accompanied by restoration of tissue 
respiration. Also, glucose promotes the inactivation of cyanides.   
 
Antidotes Accelerating Biotransformation of Poison 
 
Sodium thiosulfate is used for treatment of acute cyanide 
poisoning. The drug reacts with cyanides to produce nontoxic 
metabolites which are excreted with the urine.  
Ethyl alcohol (Ethanol) is used for treatment of methanol 
poisoning. Ethanol interacts with alcohol dehydrogenase and 
prevents the formation of formaldehyde and formic acid that cause 
metabolic acidosis. Also, ethanol prevents blindness which is caused 
by methanol.   
 
Antidotes –  Pharmacological Antagonists  
 
Atropine is used for treatment of cases with poisoning by M-
cholinomimetics and cholinesterase inhibitors. Naloxone and 
naltrexone are antagonists of opiod receptors and are used for treatment 
of opioid analgesic poisoning (morphine, heroin, etc.). As a rule, 
antidotes, pharmacological antagonists, interact with same receptors as 
poisons. Thus, creation of specific antibodies against substances which 
are the most common cause of poisoning is promising. Sooner the 
antidotes are administered, the better is the therapy result. In already 
developed pathology of tissues, organs, and systems, the efficacy of 
antidote therapy is reduced. Especially low efficacy of  
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antidotes is in the treatment of patients in terminal stages of 
poisoning.   
 
Symptomatic Therapy of Acute Poisonings 
 
Symptomatic therapy has especially important meaning in 
treatment of poisonings caused by substances which have no specific 
antidotes. First of all, it is necessary to maintain vital functions of the 
organism – blood circulation and respiration.   
In inhibitory breathing, it is necessary to clean the mouth and 
pharynx from contents. After that, the mechanical ventilation is 
carried out. If necessary, cough reflex may be provoked. For that, the 
inserted through the nose catheter is used for irritation of the 
epiglottis. A 2 % sodium chloride solution or a 3 % sodium 
hydrocarbonate solution are inhaled for reduction of sputum 
viscosity. Trypsine or acetylcysteine are inhaled in the presence of 
purulent sputum. Antispasmodic agents are added to inhaled 
solutions.  
Centrally acting analeptics are used only in cases of moderate 
inhibition of central nervous system.  
An elimination of hypoxia and pulmonary edema are the primary 
tasks in patients with acute heart failure. Thereto, the fluid pumping 
from the lungs is fulfilled. Also, antifoam agents are administered 
(ethyl alcohol or antifomsilan). In Bobrov’s apparatus, oxygen is 
passed through water with added ethanol (10 mL of 30–40 % 
ethanol). Antifomsilan is used as aerosol or administered (5–8 drops) 
into the respiratory ways. In the case of progressive hypoxia, the 
artificial respiration is used. Ganglion blockering drugs are used for 
decreasing preload and afterload of the heart. Simultaneously, 
furosemide is administered. It increases diuresis and reduces the 
circulating blood volume that results in decreasing preload. It is 
necessary to notice that osmotic diuretics are contraindicated in such 
cases. Also, cardiac glycosides are administered to a patient. 
Albumin is used for restriction of fluid transudation into the alveoli. 
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Prednisolone, calcium gluconate, and antagonists of H1-histamine 
receptors (e.g., dimedrolum) are used to reduce vascular 
permeability.  
In cases of acute vascular failure, the therapy is directed to the 
cause of intoxication. If poison is unknown, the treatment of acute 
vascular insufficiency is carried out in the following sequence. 
Prednisolone is administered first, and then plasma or 
macromolecular plasma-substituting agents are administered. These 
measures normalize the blood pressure and increase the urine 
excretion. If hypotension persists, the vasoconstrictors are 
administered: noradrenaline, mesatonum (phenylephrine), or 
angiotensinamide. In cases of circulatory centralization, ganglion 
blockering drugs or dopamine are administered. Ephedrine and 
adrenaline are contraindicated at poisoning caused by gasoline, 
kerosene, and turpentine because these drugs can provoke cardiac 
arrhythmias. If, despite all measures fulfilled, the blood pressure 
remains low, the administration of noradrenaline or mesatonum is 
continued on the background of corticosteroids and ganglionic 
blockering drugs. Simultaneously, sodium hydrocarbonate and 
trisaminum are administered for elimination of acidosis. Glucose, 
insulin, and vitamins are administered for metabolism normalization.  
Diazepam, sodium oxibutirate, or barbituric acid derivatives are 
administered in case of hypoxic convulsions. It is necessary to 
remember that barbiturates are dangerous due to their ability to cause 
the respiratory inhibition.   
In case when marked hypoxia results in brain edema, 
furosemide, glucocorticoids (prednisolone, dexamethasone), ascorbic 
acid, and phenobarbital are administered. 
Hyperthermia can develop due to hypoxia or poison influence 
upon the thermoregulatory center. Organism cooling may be carried 
out by means of the cold which is applied upon the head and regions 
of large vessels. Also, antipyretic drugs are administered 
intramuscularly or intravenously together with dibazolum or 
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benzohexonium (for the increase of heat emission). In severe cases, 
dimedrolum or diprazine are administered. 
An acute hepatic failure commonly develops due to toxic 
influence of chlorine-containing substances, tetracyclines, 
phosphorus organic compounds, poison of Amanita phalloides, etc. 
In such cases, a 20–40 % glucose solution is administered together 
with insulin and vitamins of group B.  
Acute renal failure occurs in poisoning by heavy metals, 
formalin, arsenic, Amanita phalloides, hypnotic drugs, etc. In such 
cases after antidotes administration, the drugs for elimination of 
water-salt disturbances (plasma, glucose with insulin, isotonic 
sodium chloride solution), and diuretics (furosemide, mannitol) are 
administered. Gastric lavage and saline laxative drugs are used for 
elimination of excessive potassium in patients with anuria. In case of 
aggravation of patient condition, hemodialysis is carried out.   
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